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INTRODUCTION 
The bony pelvis and its enveloping soft tissues are a common 
site for bone and soft-tissue tumors. Five percent of primary 
malignant bone tumors involve the pelvis. Osteosarcoma in 
adolescents, Ewing’s sarcoma in children and chondrosarcoma in 
adults are the most common primary sarcomas in this location. More 
commonly, though, neoplasms involving the pelvis occur as a result 
of metastatic spread from the breast, lung, prostate, kidney or 
thyroid. 
Until the late 1970s most pelvic tumors were treated with 
External hemipelvectomy, a procedure that was associated with a 
significant percentage of complications and a dismal functional and 
psychological outcome.  
The 1st successful hemipelvectomy was reported by Charles 
Girard in 1895, for a recurrent osteosarcoma. 
With the advent of more accurate imaging modalities, newer 
chemotherapeutic agents, use of neoadjuvant chemotherapy, 
improved resection techniques, and prosthetic reconstruction, limb-
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sparing procedures are now performed in the majority of these 
cases.  
Sacral tumors comprise a heterogeneous group of neoplasms 
ranging from benign, benign aggressive, malignant, and metastatic 
in origin. Patients presenting with sacral neoplasm range in age from 
very young with teratomas to very elderly with metastatic disease.  
In 1948, Bowers' described a patient with an aggressive 
hypervascular pulsatile giant cell tumor of the sacrum. An initial 
posterior approach to the lesion was abandoned because of severe 
bleeding. He concluded that the vascularity was not provided by 
the middle and lateral sacral vessels as believed, but more likely by 
both the common and internal iliac vessels. He proceeded with a 
second two-staged, carefully thought out procedure two weeks 
later. 
The lesion was first approached anteriorly through a 
transperitoneal left rectus incision where a pulsatile mass could be 
palpated behind the rectosigmoid. Mobilization and umbilical tape 
occlusion of both common iliac vessels ceased pulsations within the 
mass. Both internal iliac vessels were hypertrophied and were found 
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to enter into the mass and were ligated and transected while the 
umbilical tapes around both common iliac vessels remained in 
place. Patient turned to the prone position. The previous longitudinal 
posterior sacral incision performed 2 weeks earlier was reopened 
and the amputation through S2 was completed, retaining only the 
first sacral nerve roots bilaterally. The wound was drained and closed 
and the patient then turned supine once again. The wound was 
reopened and the umbilical tapes removed after 2 hours and 45 
minutes. Both common iliac and femoral pulses returned to normal 
without complication. 
MacCarty et al described their early surgical experience at the 
Mayo Clinic for management of sacral tumors in 1952. They 
preferred a single posterior approach with some lesions extending 
up to S1.  
In the same year, Hays reported a 2.5-year follow-up of a 
patient initially managed with radiotherapy for giant cell tumor, then 
6 weeks later with sacral amputation  including the rectum, and 
preserving the first sacral nerve roots. Localio et al also described 
their experience with a two-position procedure for surgical 
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management of Chordoma in 1967. 
 In 1978, Stener and Gunterberg described in detail the currently 
accepted principles and technique of sacral amputation supported 
by a report of their clinical experience. The surgical principles and 
techniques described by them remains the standard by which other 
reports on terminal resection of the sacrum are judged. 
Extensive pelvic surgeries are highly demanding because of the 
irregular and complex shape of the bony pelvis, numerous muscle 
attachments, and the proximity of major blood vessels, nerves, and 
visceral organs. Given the complexity of the anatomy and the use of 
adjuvant therapies that require an uncomplicated and expedient 
postoperative recovery, osseous pelvic resections remain one of the 
greatest surgical challenges.  
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AIM OF THE STUDY 
1) To analyze the surgical management of musculoskeletal tumors 
in pelvis  
2) To analyze the morbidity & mortality associated with the 
management of musculoskeletal tumors in pelvis 
3) To analyze the oncological & functional  outcome of 
musculoskeletal tumors in pelvis and compare with that of 
literature 
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LITERATURE REVIEW 
SACRAL TUMORS 
Most common primary sacral tumors are Chordoma, giant cell 
tumor, chondrosarcoma and plasmocytoma. Secondary infiltration 
of sacrum from carcinoma rectum and retroperitoneal tumor can 
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occur. Most common tumors requiring sacrectomy are primary 
sacral tumors and rectal carcinoma infiltrating the sacrum.  
Characteristically, the primary tumors progress slowly to involve 
adjacent structures. Eventually, the sacral nerve roots coursing 
through the sacrum are invaded, which then cease to function.  
The symptoms produced by these tumors are often vague, 
ranging from local pain to ill-defined lower lumbar pain associated 
with radicular symptoms commonly confused with the more 
common lower lumbar back and nerve root compression 
syndromes. The symptoms, however, tend to involve both lower 
extremities and are only late to produce the commonly suspected 
bowel and bladder dysfunction.  
 
 
EVOLUTION OF SACRECTOMY:  
Attempts to resect primary and metastatic lesions of the 
sacrum have intrigued surgeons for years, as is evident from 
numerous reports. Sacrectomy was performed by many surgeons like 
12 
 
Bowers in 1948, MacCarty et al (Mayo clinic) in 1952. The technique 
of two position procedure was popularized by Hays et al in 1952 and 
Localio during 1967.  
In 1978, Stener and Gunterberg described the currently 
accepted principles and technique of sacral amputation. The 
surgical principles and techniques described by them remains the 
standard by which other reports on sacral resection are judged. 
Wanebo et al described a two-stage approach, beginning with an 
anterior procedure, followed by a posterior procedure after 1 or 2 
days. 
SACRECTOMY: 
 
Better understanding of the sacral anatomy and biomechanics 
of lumbosacropelvic region is an important factor for a successful 
surgical and functional outcome. At present sacrectomy requires 
team work, incorporating surgical oncologist, neurosurgeon, plastic 
surgeon, physiotherapist and oncological nurse for a better surgical 
and functional outcome. Preoperative counseling with the patient 
and relatives about the nature surgery, long duration of immobility, 
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functional and surgical outcomes will have a better psychological 
impact and co-operation. 
Preoperative imaging with plain X-ray pelvis AP view, CT scan 
abdomen and pelvis and/or MRI is essential for planning. 
Involvement of L-5 spine, extensive side wall involvement, distant 
metastatic disease and poor general condition negate surgery. 
Involvement of rectum necessitates enbloc resection and planning 
for colostomy also. So, meticulous bowel preparation is advisable 
preoperatively along with perioperative antibiotics. 
Sacral resection presents a formidable challenge due to the 
following factors: (1) Technical complexity and difficulty often 
requiring combined anterior transabdominal and posterior 
lumbosacral approaches; (2) uncertainties or difficult decisions 
regarding loss of anorectal and urogenital function and control. (3) 
Questions regarding weight-bearing stability of retained sacroiliac 
postural support. 
Approaches for sacrectomy: 
Various approaches like anterior (transabdominal or 
retroperitoneal), posterior that involves sacral laminectomy, 
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sequential anterior and posterior (Bowers), synchronous 
abdominolateral (Localio) with lateral decubitus position, sequential 
anterior and posterior with myocutaneous flap (Stener and 
gunterburg) and perineal approach are described for sacrectomy. 
Wanebo et al described a two-stage approach, beginning with an 
anterior procedure, followed by a posterior procedure after 1 or 2 
days. 
Sequential anterior and posterior approach which is indicated 
in tumors with anterior extension and significant involvement of S1 
and S2 segment is commonly used. Tumors below sacro-iliac joint 
can be approached posteriorly. 
The major advantages of the posterior transsacral approach are its 
familiarity, wide access to the intraspinal and intradural compartments, 
and clear differentiation between tumor and neural tissue. It is the 
procedure of choice for the removal of intraspinal tumors with little or 
no presacral extension. Incisional biopsy or intralesional curettage of sacral 
body tumors is also easily performed posteriorly. Any significant presacral 
extension is not adequately exposed for marginal resection from this 
approach and will require either a staged or simultaneous anterior 
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procedure. 
 Localio described the synchronous abdominolateral approach 
in which the patient is placed in lateral decubitus position which 
gives both anterior and posterior exposure. There is no need for 
patient repositioning and less blood loss in this approach but 
exposure is limited and the efforts at mechanical stabilization and 
soft tissue reconstruction are complicated. This approach allows 
simultaneous unilateral ventral and dorsal exposure of the sacroiliac 
joint. It is suited for en - bloc resection of malignant tumors such as 
chondrosarcoma, osteosarcoma, and giant cell tumor, which cross 
the sacroiliac joint to involve both the lateral sacral ala and medial 
iliac wing. 
The abdominosacral approach is the most versatile and widely 
employed of the combined exposures. With anterior approach, internal 
iliac vessels are ligated; common iliac and external iliac vessels are 
isolated and safeguarded. Rectum is dissected away from sacrum. 
So, chances of vessel injury, blood loss and rectal injury are reduced.  
Omental flap transposition is possible with this approach. This 
approach is mandatory in patients requiring rectal resection. With 
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posterior approach, sacral and lumbar laminectomy is done and 
dural sac is carefully ligated to prevent CSF leakage and potential 
development of meningitis.  But patient needs repositioning. 
Low and High Sacrectomy: 
The level of amputation, if possible, should be one sacral 
segment above the most rostrally involved segment as determined 
by preoperative imaging. Low sacrectomy (S3 or below) is relatively 
simple because the osteotomy is performed below the sacroiliac 
joint. It is most easily performed through the sacroperineal route, 
although more complicated cases, such as those with rectal 
involvement or operation for recurrent tumor, may require an 
abdominosacral exposure. Because the S3 nerve roots can usually 
be spared with low sacrectomy, urogenital and anorectal function 
can be preserved. 
Progressively higher sacrectomy presents proportionally greater 
risks of morbidity. Blood loss, particularly during osteotomy of the 
sacrum and ilium, can be profuse and the large dead space left by 
the resected specimen may result in significant wound 
complications. Since high sacrectomy requires amputation of the 
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dural sac, these complications are compounded if the thecal 
closure is not watertight.  
Preservation of S2, at least unilaterally, will often preserve 
voluntary uroanal sphincter control. Preservation of the S2 root should 
always be attempted, but not at the expense of violating the tumor 
margin. Lower limb function is only minimally affected with even total 
sacral root division but may be significantly impaired if the nearby 
lumbosacral trunk, gluteal, or sciatic nerves are injured during the 
resection. 
Spino-pelvic reconstruction: 
Subtotal resection of the sacrum caudal to the midportion of 
the S-1 vertebral body does not destabilize the pelvis. Total 
sacrectomy requires reconstruction of the pelvic ring plus 
establishment of a bilateral union between the lumbar spine and 
iliac bone. 
Structurally, preserving the upper one half of the body of SI will 
retain sufficient bone and continuity of the obliquely positioned 
sacroiliac joint to permit immediate unprotected weight bearing. 
Resections including the entire body of S1 and preserving only the L5 
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nerve root will require posterior pedicle instrumentation with fixation 
to both iliac crests and additional bone grafts. 
 These patients should be either immobilized or limited to bed or 
chair activities until sufficient bone healing is present to permit 
weight bearing. Sacral rim stability is maintained if the resection line 
can be kept in the lower one half of the S1 vertebra. Fifty percent of 
S1 should be preserved so long as a tumor-free margin is maintained.  
Reconstruction has been described by various methods like 
Galveston reconstruction system, modified Galveston reconstruction 
system, sacral bar and compression rods, Harrington compression 
plates, posterior and anterior instrumentations, triangular frame 
reconstruction etc. 
Management of sacral defect after sacrectomy: 
           Most patients developed wound problems like dehiscence 
and flap necrosis. This is due to proximity to the anus, extensive 
resection creating large defects, ligation of internal iliac vessels and 
suturing with tension. Rectum may be exposed after wound 
dehiscence which may be avoided by covering the rectum with 
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omentum and use of flaps. Meticulous hemostasis, obliteration of 
dead space, and prophylactic antibiotics will help prevent infection. 
 Reconstruction of the soft tissue defect after sacrectomy has 
been done with Transabdominal Vertical Rectus Abdominis 
Myocutaneous Flap (VRAM flap), Gluteal advancement flap or free 
flaps.  
In our series, Gluteal advancement flap was done which 
significantly reduced the post operative wound dehiscence & 
morbidity. 
 
HEMIPELVECTOMY 
In spite of increasingly effective chemotherapy and advances 
in limb-sparing surgery around the pelvis and hip, hindquarter 
amputation (hemipelvectomy) often remains the optimal surgical 
treatment for primary tumors of the upper thigh, hip, or pelvis. 
Hemipelvectomy may also be life-saving for patients with massive 
pelvic trauma or uncontrollable sepsis of the lower extremity, and it 
can provide significant palliation of uncontrollable metastatic lesions 
of the extremity. 
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The terms “hindquarter” amputation and “hemipelvectomy” 
are often used interchangeably to refer to any amputation 
performed through the pelvis. Older terms used to describe this same 
procedure include interpelviabdominal or interinnomino-abdominal 
amputation.  
The advent of limb-sparing pelvic resections has necessitated a 
distinction between internal and external hemipelvectomy, 
depending on whether preservation of the ipsilateral limb is 
performed. Confusion caused by the term “internal 
hemipelvectomy” can be avoided by use of a standardized 
classification for pelvic resection. 
Sugarbaker and others have shown the utility of a 
myocutaneous pedicle flap based upon the femoral vessels and 
anterior compartment of the thigh for closure of the wound in 
patients with tumor involving the posterior buttock structures. This 
procedure has been termed an “anterior flap hemipelvectomy”, to 
distinguish it from the more common “posterior flap 
hemipelvectomy”. Anterior flap hemipelvectomy is indicated for 
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tumors that involve the buttock and for selected patients in whom a 
well-vascularized flap is required for coverage. 
There are subtypes of the posterior flap hemipelvectomy. The 
term “classic hemipelvectomy” is used to refer to amputation of the 
pelvic ring via disarticulation of the pubic symphysis and the 
sacroiliac joint (SI), division of the common iliac vessels, and closure 
with a posterior fasciocutaneous flap. 
Classic hemipelvectomy is typically necessary for large tumors that 
arise within the pelvis.  
“Modified hemipelvectomy” refers to a procedure that 
preserves the hypogastric (internal iliac) vessels and the inferior 
gluteal vessels supplying the gluteus maximus, permitting creation of 
a vascularized myocutaneous posterior flap for wound closure. This 
term also describes any and all variations from the classic operation, 
including resection through the iliac wing or contralateral pubic 
rami. Modified hemipelvectomy is most commonly performed for 
tumors involving the thigh and/or hip, when a limb-sparing 
alternative is contraindicated.  
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“Extended hemipelvectomy” refers to a resection of the 
hemipelvis through the sacral ala and neural foramina, thereby 
extending the margin for tumors that approach or involve the Sacro 
Iliac joint.  
Regardless of the type of flap created for closure, the term 
“compound hemipelvectomy” is used to describe resection of 
contiguous visceral structures such as bladder, rectum, prostate, or 
uterus. (Patients suspected of having tumor extending into viscera, or 
an extremely large tumor filling the pelvic fossa, can be approached 
through an intraperitoneal incision.) 
Anterior Flap Hemipelvectomy: 
 
The anterior flap hemipelvectomy is a modified version of the 
classical posterior flap hemipelvectomy. Instead of utilizing the 
traditional posterior skin flap of the gluteal region, a myocutaneous 
flap from the anterior thigh is used to close the peritoneum following 
amputation through the sacroiliac joint and the pubic symphysis.  
This modification has permitted the treatment of difficult 
buttock and pelvic tumors where the posterior flap was involved 
and/or contaminated by tumor. This technique offers patients, 
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initially thought to be incurable by standard technique, a good 
oncological procedure.  
The anterior myocutaneous flap consists of a portion or the 
entire quadriceps muscle group on its vascular pedicle, the 
superficial femoral artery. This flap covers the entire peritoneal 
surface and generally heals with minimal problems. 
Patients with extensive soft-tissue sarcomas of the buttock or 
bone sarcomas of the pelvis that extend posteriorly, once thought to 
be incurable by standard posterior flap hemipelvectomy, can often 
be treated with an anterior flap hemipelvectomy.  
The procedure, which originally entailed use of an anterior skin 
flap raised off of a portion of the superficial femoral vessels, was later 
modified to include a full-thickness myocutaneous flap raised from 
the anterior thigh. This procedure may also be indicated following 
failed attempts at limb-sparing surgery, as well as for patients with 
nononcologic indications for amputation (e.g. uncontrollable sepsis 
from sacral or trochanteric osteomyelitis). 
 The major advantage of anterior flap hemipelvectomy is the 
creation of a large vascularized myocutaneous flap that is ideal for 
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closure of significant posterior defects. As much of the anterior thigh 
compartment may be saved as needed, depending on the size of 
the defect being closed.  
As always, careful patient selection is critical in ensuring that an 
acceptable outcome is achieved. For example, elderly patients and 
diabetics with silent atherosclerotic disease of femoral vessels must 
be carefully evaluated with preoperative angiography. The 
suitability of this procedure may also be limited by the anatomic 
location of the tumor. 
The primary advantage of this procedure is that the anterior 
flap raised from the thigh can be used to reconstruct an enormous 
posterior defect with little risk of flap necrosis. Patients who are 
expected to require radiation postoperatively should be considered 
for this procedure whenever possible, since the well-vascularized 
myocutaneous flap tolerates radiation well. Because of the vascular 
nature of this flap, the surgical wound heals rapidly in the vast 
majority of patients.  
Accordingly, the 10–30% risk of ischemic necrosis associated 
with posterior flap hemipelvectomy is not seen with an anterior flap 
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procedure. Likewise, the risk of subsequent infection in the 
postoperative period is markedly reduced. Great care must be 
taken not to dissect or shear the subcutaneous tissue and skin 
overlying the quadriceps during the creation of the flap, because 
this will compromise the cutaneous circulation. 
Rehabilitative considerations and the risk of phantom pain are 
similar to those associated with other types of hemipelvectomies. 
Because of the rapid healing seen with this type of flap, prosthetic 
fitting may be performed earlier. The large mass of quadriceps 
muscle provides a cushion of viable tissue on the sacrum on which 
prosthesis may comfortably rest without traumatizing the overlying 
skin. 
 
PELVIC RESECTIONS: 
The pelvic girdle is a common location for primary bone 
sarcomas and metastatic lesions with the periacetabular region 
being the most common location, followed by the ilium and the 
pubis. Hemipelvectomy, the classic treatment for these lesions, has 
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been associated with dismal functional and psychological 
outcomes.  
Improved survival of patients with musculoskeletal 
malignancies, and refinements in surgical technique, has allowed 
the execution of limb-sparing procedures in these situations. Local 
tumor control is good, as is the probability of a functional extremity. 
Internal hemipelvectomies, which involve resection of part or all of 
the innominate bone with preservation of the extremity, are now a 
reliable surgical option in the treatment of primary bone sarcomas, 
benign-aggressive lesions, and metastatic tumors of the pelvic girdle. 
 
Classification of Pelvic Resections 
Hindquarter amputation (hemipelvectomy, classical 
hemipelvectomy), using a posterior subcutaneous flap, was for a few 
decades the standard of treatment for large bone or soft-tissue 
tumors involving the proximal thigh, groin, or the periacetabular 
region. Extended hemipelvectomy includes sacral transection 
through the neural foramina. If a part of the iliac crest is spared, the 
procedure is referred to as modified hemipelvectomy.  
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Hemipelvectomy can be performed using either the standard 
posterior or anterior myocutaneous flaps. If the tumor mass is located 
in the buttock or high in the posterior thigh, and does not involve the 
femoral vessels, an anterior flap hemipelvectomy should be 
performed. In this procedure the surgical defect created by 
resection of the hemipelvis is covered by a rectus femoris 
myocutaneous flap.  
Internal hemipelvectomy (Pelvic resection) involves resection of 
part or all of the innominate bone with preservation of the extremity. 
The classification of these resections is attributed to Enneking and is 
based on the resected region of the innominate bone, from 
posterior to anterior: 
 Type I – ilium 
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 Type II - periacetabular region 
 Type III – pubis 
 Extended Type I or Type IV resection - En-bloc resection of the 
ilium & sacral ala 
 Type I pelvic (ilium) resection can be either (A) partial, in which 
only part of the ilium is transected, or (B) complete.  
                 A: TYPE I PELVIC 
RESECTION   
  B: TYPE II PELVIC RESECTION  
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  C: TYPE III PELVIC RESECTION 
The Utilitarian Pelvic Incision: 
The most useful approach to pelvic biopsy or resection is the 
utilitarian pelvic incision. All or part of the incision can be used for 
adequate exploration and resection of the majority of pelvic girdle 
tumors.  
The incision begins at the posterior inferior iliac spine and 
extends along the iliac crest to the anterior superior iliac spine. It is 
separated into two arms: one is carried along the inguinal ligament 
up to the symphysis pubis, and the other turns distally over the 
anterior thigh for one-third the length of the thigh and then curves 
laterally just posterior to the shaft of the femur below the greater 
trochanter and follows the insertion of the gluteus maximus muscle. 
Reflection of the posterior gluteus maximus flap exposes the proximal 
third of the femur, the sciatic notch, the sacrotuberous and 
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sacrospinous ligaments, the origin of the hamstrings from the ischium, 
the lateral margin of the sacrum, and the entire buttock.  
A significant concern exists regarding the possible 
extracompartmental implantation of tumor cells following biopsy or 
resection of a pelvic tumor, procedures that are difficult to perform 
under optimal hemostatic conditions. Unnecessary biopsies must 
therefore be avoided. If biopsy is indicated, the proper technique 
and a suitable approach must be chosen. The biopsy tract has to be 
positioned along the line of the future utilitarian incision, remote from 
the major neurovascular bundle and the abductors.  
CT-guided core needle biopsy is considered to be an accurate 
and safe diagnostic tool in the diagnosis of musculoskeletal tumors 
and is the preferred modality used by the authors.  
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Picture Showing the Utilitarian Pelvic Incision 
 
The utilitarian incision may be used for hemipelvectomy by 
continuing the distal portion of the primary incision posteriorly around 
and behind the thigh and bringing it anteriorly along the inferior 
pubic ramus to the symphysis, thus encircling the thigh but still 
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allowing the large posterior flap to be used for primary  wound 
closure. 
Tumor evaluation 
The presence of a palpable mass and its location, size, increase 
in local warmth, pulsatile nature, and degree of tenderness should 
be assessed by physical examination and the information recorded. 
Routine roentgeno-grams are sometimes helpful, but CT and 
especially MRI are essential. 
 Vascular studies of the lower extremity are sometimes useful in 
assessing the degree of partial occlusion, venous obstruction, or 
simply the proximity of the tumor to the vessels. An 
electromyography is sometimes useful in assessing the degree of 
damage to the nervous system; a CT of the chest and abdomen, a 
bone scan, and a positron emission tomographic scan frequently 
are helpful in determining the presence and extent of metastases. 
 A biopsy is an essential part of the tumor evaluation and can 
be obtained with greater accuracy by CT-guided core needle 
biopsy. An open biopsy may be necessary, but it should be through 
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the smallest possible incision, designed to be readily resectable at 
the time of definitive surgery. 
Biopsy Technique: 
General guidelines regarding positioning of the biopsy tract are 
applicable to biopsies of bone and soft tissue lesion and are 
independent of the technique 
(Open versus needle biopsy) and anatomic location.  
These guidelines can be summarized as follows:  
 Most representative part of the lesion should be selected.  
 As a rule the extraosseous component of a malignant bone 
tumor is as representative of the tumor as is the bony 
component, and should have biopsy, if present.  
 Violating the cortex of a bone that harbors a malignant tumor, 
predisposes the patient to a pathologic fracture, and is 
recommended only if there is no extraosseous extension of the 
tumor.  
 Position the point of entry along the planned incision of the 
definitive surgery 
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 The biopsy tract must be the shortest way to the lesion; 
however, it must not violate more than one compartment and 
must be as remote as possible from the main neurovascular 
bundle of the extremity. 
The biopsy technique and placement is of paramount 
importance in periacetabular tumors as the risk of peritoneal and 
pelvic contamination is considerable and local control is a greater 
challenge. A misplaced or poorly performed biopsy can lead to 
extensive soft-tissue contamination and render resection difficult or 
not feasible. A poorly performed biopsy may be the primary reason 
a patient has a hemipelvectomy, and it may even interfere with soft 
tissue flaps necessary for wound coverage.  
Most patients with periacetabular tumors are best served with a 
needle biopsy placed in the incision line of the planned future 
resection. CT guidance should be used unless there is a large 
extraosseous component that is easily accessible and away from 
critical neurovascular structures. The needle biopsy is performed 
anteriorly. The posterior approach should be avoided so as not to 
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contaminate the gluteus maximus, hip joint, femoral vessels, and 
femoral nerve.  
For biopsy of the sacral tumors, the following guidelines are 
recommended (apart from the general guidelines): 
• The biopsy site should be placed in the midline posteriorly, 
along the line of incision  
• It should be placed in such a way that it should facilitate a 
contiguous en-bloc resection of the needle tract and tumor at 
the time of definitive surgery. 
• should not contaminate the gluteal muscles  
• should not be done transrectally or transperitoneally 
Treatment planning 
To provide the best possible treatment, the information 
obtained from the studies described previously must be reviewed 
carefully by a team that consists of the surgical oncologist, a 
medical oncologist, a radiation oncologist, a pathologist, and a 
radiologist, all of whom have experience and knowledge regarding 
bone and soft-tissue tumors. Based on the size, location, and nature 
of the tumor, the presence or absence of metastases, and the 
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patient's age and health status, a protocol must be established that 
could consist of one of the following: 
• Wide or marginal surgical resection 
• Surgical resection followed by radiation or chemotherapy or 
both 
• Neoadjuvant chemotherapy or radiation therapy followed by  
surgery and, if necessary, additional adjuvant therapy 
• Palliative radiation or surgery as necessary to address 
metastatic spread    
and local tumor by appropriate measures 
Surgical techniques 
Surgical approaches and techniques vary depending on the 
location of the tumor and the planned resection.  
• For tumors of the iliac wing, the best approach is frequently 
along the iliac crest, which allows access to the anterior and 
posterior aspects of the tumor but may —if the tumor is large 
enough—causes some degree of skin vascular impairment.  
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• For tumors of the pubic rami, the longitudinal incision that runs 
along the pubis and extends to the ilium laterally and across 
the symphysis medially is often the simplest. 
• For tumors of the ischium, an incision along the ischiopubic 
region that extends down the medial thigh and, if necessary, 
across the symphysis and into the region of the hip joint seems 
best. 
• For tumors of the acetabular region, an anterior or lateral 
approach that extends into the thigh to add a hip 
replacement system is logical and relatively straightforward. 
• For a total pelvic resection, either an extensive anterior 
approach (Smith-Petersen approach) or a long lateral incision 
starting at the crest and extending into the thigh is usually 
necessary. 
Reconstruction 
Techniques of surgical reconstruction include: ischiofemoral 
arthrodesis, iliofemoral arthrodesis, pelvic allograft, custom prosthesis, 
flail extremity, and, more recently, custom saddle prosthesis. 
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• Resection of the pubis often can be treated without any type 
of replacement or with an auto- or allograft insertion. 
• Resection of the ischium usually requires no replacement 
system. 
• Resection of a portion of the ilium need not be replaced unless 
the lesion area lies in juxtaposition to the sacrum, in which case 
an auto- or allograft can be implanted to maintain structure 
and function. 
• Resection of the entire ilium and acetabulum can be treated 
by either resection and arthrodesis of the femoral head or 
trochanteric region to the sacrum or an allograft replacement 
without metallic femoral prosthesis or with a proximal femoral 
total joint  
 
Reasons for poorer results in the management of pelvic tumors: 
Although some authors have described reasonably good 
results for the treatment of some pelvic lesions, based on literature 
surveys there is little doubt that the treatment of patients with high-
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grade sarcoma and metastatic carcinoma of the pelvis is 
considerably more difficult than for other sites. 
The failure rate is higher, the disability levels are greater, and, as 
noted in this effort and in many others, the survival rate is 
considerably poorer. The question is not that it is so; all data support 
that. The two additional questions are why it is so and what can be 
done to make it better. 
In terms of the causes for a poorer survival rate, there are 
several possible explanations. 
1. The vascularity of pelvic tumors is significantly greater than in 
other more distal sites. Not only does this make the surgery more 
difficult in terms of blood loss but also it almost surely increases the 
likelihood of discharge of malignant tumor cells into the venous 
system at the time of surgery, which leads to an increased risk of 
metastasis. Another feature of the vascular issue is the internal body 
temperature at the site of the tumor, which is considerably higher 
than that for tumors in more distal sites. This may play a role in 
increasing the release of cytokines, such as the prostaglandins and 
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others, which may increase the malignancy of the tumor and the risk 
of metastasis. 
 
2. The size of the tumors is often much greater in the pelvis than in 
other sites. Although the pelvis has a collection of nerves passing 
through it, it is still possible for tumors at this site to grow much larger 
with less recognition by the patient or the examining physician as 
compared with other more distal sites or in the upper extremities. A 
lesion 10 cm in longest diameter in the calf or thigh—or especially in 
the foot or hand—is hard to ignore, but a similarly sized lesion in the 
pelvis can exist without patient awareness as long as fracture or 
neural or vascular compression does not occur. 
 
3. Surgical resection is often much more complex for pelvic 
tumors based on the proximity of blood vessels and nerves. Avoiding 
viscera and trying to save the femoral, sciatic, or obturator nerves or 
the internal iliac and femoral vessels and even some of the smaller 
arteries and veins can lead to not only a marginal resection but also 
an intralesional resection. As noted in the previous data, intralesional 
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surgical resection has a high mortality for pelvic lesions compared 
with marginal or wide resections. 
 
4. Reconstructive surgery about the pelvis is complex and 
sometimes difficult. Restoring anatomy for the hip, maintaining the 
length of the limb, and retaining the function for the muscles are 
hardly simple tasks and sometimes require far more time and 
ingenuity than procedures in other anatomic sites. The duration of 
surgery increases the likelihood of infection and anesthetic 
complications. Most patients who receive pelvic surgery for high-
grade tumors spend several days in a special care unit at our 
institution and frequently remain intubated and on intravenous fluids 
for a much longer period of time than patients who are treated for 
lesions in other anatomic sites. 
Allograft Reconstruction 
             The biological principle behind allograft reconstruction is that 
they provide a bony lattice around which host bone elements from 
the periosteum creep and fill the graft. There is a host graft 
interaction by which the graft gets fused with the host bone like 
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fracture healing. This process is not usually complete in massive grafts 
where the host bone fills the peripheries only. But this process may 
take more time than normal fracture healing. 
       The major advantages of allograft over endoprosthesis are 
immediate availability of large grafts; the grafts can be trimmed to 
suit the donor defect and suturing of the soft tissues to the graft. 
There are two types of allograft reconstruction osteoarticular and 
intercalary. Intercalary grafts have superior results than 
osteoarticular. 
        The major disadvantages are increased wound related 
complications, 15 to 20% in most series. They require prolonged 
immobilization for the union to occur. There may be non union or 
fracture. They elicit an immune reaction which may lead to 
resorption of the graft as it happened in our case. The incidence of 
immune reaction is vastly reduced after freeze drying the graft. There 
is also a potential to transmit viral disease like HIV and Hepatitis 
though it is reduced by freeze drying or gamma sterilization. 
In spite of these limitations, allograft reconstruction is an 
attractive option, because of the low cost involved and the 
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potential to acquire large number of grafts easily through 
development of bone banks. 
 
REHABILITATION AFTER TOTAL SACRECTOMY 
Physical and occupational therapists play an important role in 
improving function and increasing patients' independence with 
activities of daily living. Goal of rehabilitation is restorative with an 
emphasis on increasing functional independence while maintaining 
structural integrity of the surgical site. 
Urinary retention and rectal insensitivity requires the need for 
self catheterization and a strict bowel regimen. If only the L5 nerve is 
preserved, patients may require a brace for ambulation. They may 
have difficulty going up and down stairs secondary to partial loss of 
gluteus maximus function and decreased hip extension. Although in 
most patients hypertrophy of the hamstrings and adductor muscles 
may compensate for this loss allowing for a close to normal gait 
pattern. 
44 
 
In order to avoid shearing forces at the site of the flap 
posteriorly, sitting is contraindicated for 10 to 14 days after surgery. 
This restriction may be extended in patients who require wound 
irrigation and drainage after surgery. Therefore functional tasks and 
activities of daily living are performed in supine, sidelying, or standing 
positions. Immediately after surgery, patients are often placed on 
bed rest on a Clinitron Rite Hite Air Fluidized Therapy Bed for 1 to 3 
days. Clinitron beds are designed to promote wound healing and 
prevent skin break down. To help patients with mobility on the 
Clinitron bed a trapeze is placed above the bed to assist with bed 
mobility and transfers out of the bed. 
Physical therapy is usually initiated postoperative day 3. 
Physical therapy evaluation must include a thorough motor and 
sensory evaluation of the lower extremity, trunk, and upper extremity. 
Bed mobility, transfer training, and patient and family education are 
3 important general short-term restorative goals. Progress with short-
term goals and treatment intensity depends on patient's general 
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physical and medical condition after surgery and the presence or 
absence of postsurgical complications.  
As indicated sitting is almost always contraindicated for 10 to 
14 days after a total sacrectomy to protect the incision site and 
allow time for healing. Therefore education and independence with 
safe out of bed transfer is the primary focus of physical therapy 
intervention during the first postoperative week. To ensure patient 
independence and safety with the supine to stand transfer, patients 
are instructed in log rolling, using their upper extremities to flex the 
trunk and assisted in lower extremity transfer out of bed. This transfer 
is often done with maximum assistance of 2 therapists during the first 
1 to 3 days after the initial evaluation. The level of assistance is 
gradually decreased based on patients' progress with the 
technique. A realistic short-term goal (3 days after initial evaluation) 
would be a transfer out of bed that requires minimum to moderate 
assistance of one person. 
Patient, family, and the nursing staff are educated on transfer 
training as well as proper positioning in bed with periodic sidelying to 
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prevent skin breakdown. In addition to the training provided by 
physical therapists, patients work with occupational therapists to 
gain independence in self care activities.  
Occupational therapy is often initiated at the same time as 
physical therapy. Prior to discharge from the hospital the nursing staff 
educates patients on self catheterization and bowel regimen; 
however, patients often times need home care services to help 
them with this postoperative complication. 
 Most patients are discharged home with an ability to transfer 
out of bed independently and ambulate 250 to 500 feet with a 
rolling walker. Rehabilitation following total sacrectomy is 
challenging and rewarding at the same time. Increasing patient 
independence and safety with transfers while maintaining sitting 
restriction is one of the hardest goals to achieve during therapy. The 
intensity and progression of therapy is often limited due to the long 
surgical procedure, extensive blood loss, and possible complications 
following surgery. 
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MATERIALS AND METHODS 
The patients who were diagnosed to have musculoskeletal tumors of pelvis 
and operated (either Sacrectomy/ Hemipelvectomy or Pelvic resection) in the 
Department of Surgical oncology, Government Royapettah Hospital, (Kilpauk 
Medical College) Chennai, Tamil Nadu were included in the study. The study 
period is from February 1997 to May 2009. 
Pre operative work up included chest X-ray, CT scan and/ or MRI of pelvis, 
CT scan chest, Biopsy either in the form of core needle biopsy, CT guided Biopsy 
or Open biopsy(when the previous methods fail) assessment of cardiopulmonary 
status and routine blood investigations.  
Each patient is discussed in the panel headed by the surgical oncologist, a 
medical oncologist, radiation oncologist, oncopathologist, radiologist, 
physiotherapist, rehabilitation personnel & stoma therapist. Surgery done may be 
in the form of either:  
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• Sacrectomy → partial/ subtotal/ total/ Hemisacrectomy/ partial 
sacrectomy with curettage.   
or 
• External Hemipelvectomy 
or 
• Pelvic resection (Type I/II/II/IV) 
Sacrectomy is done with either one of the following approaches: 
• Posterior approach 
• Sequential abdominosacral approach 
• Staged abdominosacral approach 
Pelvic resection is done with utilitarian pelvic incision approach 
Duration of surgery, blood loss, length of hospital stay, post operative 
complications, local recurrence, distant metastasis, survival rate, use of adjuvant 
therapy, functional outcome measures including ambulatory ability and bowel & 
bladder control were analyzed. 
Patients were followed up monthly for the 1st year, once in 2 months for the 
2nd year, 3 monthly thereafter. Clinical examination, imaging with CT scan was 
done during follow up.  
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Survival analysis done with Kaplan meier method (with spss). Functional & 
Oncological outcome was analyzed and the results were compared with that in the 
literature. 
 Functional outcome in our series is measured by a self designed Royapettah 
scoring scale for assessing the functional outcome of musculoskeletal tumors of 
pelvis treated with sacrectomy/hemipelvectomy (given in the proforma). 
ANALYSIS AND RESULTS 
In this series of 26 patients with musculoskeletal tumors of pelvis, 
17 patients underwent Sacrectomy, 8 patients underwent Pelvic 
resection and 1 patient underwent External Hemipelvectomy (Chart 
No 1).  
The common diagnosis in our series is listed in the Table No 1 & 
2.In our series, Giant cell tumor (n=7) is the most common sacral 
tumor, followed by Chordoma (n=6). Chondrosarcoma is the most 
common pelvic tumor treated with pelvic resection.  
The average age at diagnosis was 33 years (range 15-65 years). 
There were 16 males and 10 females. 2 patients were given 
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neoadjuvant chemotherapy and taken for surgery (PNET Pelvis, 
Ewing’s sarcoma Pelvis).  
Partial Sacrectomy was done in 6 patients, Partial Sacrectomy 
with Curettage in 2, Total Sacrectomy in 4, Subtotal Sacrectomy in 3, 
Subtotal Sacrectomy with Type I Pelvic Resection in 1 and 
Hemisacrectomy in 1 patient. 
 Type IV Pelvic Resection in 4, Type I/II/III Pelvic Resection (or 
combined) in 4 and External Hemipelvectomy (Anterior Flap 
Hemipelvectomy) in 1 patient. (Table No 3). 
  
Table No 1 
SACRAL TUMORS n 
Giant cell tumor 7 
Chordoma 6 
Myxopapillary Ependymoma 1 
Chondroblastoma 1 
Primitive Neuroectodermal tumor 1 
Chondrosarcoma 1 
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Table No 2 
PELVIS TUMORS (excluding sacral tumors) n 
Chondrosarcoma 4 
Hemangioendothelioma 1 
Aneurysmal Bone Cyst 1 
Primitive Neuroectodermal tumor 1 
Ewing's sarcoma 1 
Malignant peripheral Nerve sheath tumor 1 
 
Table No 3 
SURGERY SURGERY n 
Total Sacrectomy 4 
Subtotal Sacrectomy 3 
Subtotal Sacrectomy + Type I 
Pelvic Resection 
1 
Partial Sacrectomy 6 
 
 
 
SACRECTOMY 
Partial Sacrectomy with 
Curettage 
2 
52 
 
 Hemisacrectomy 1 
Type IV Pelvic Resection 4 
Type I+II Pelvic Resection 1 
 
 
PELVIC RESECTION Type II+III Pelvic Resection 3 
External Hemipelvectomy  Anterior Flap Hemipelvectomy 1 
 
Anterior Flap Hemipelvectomy was done in a 16 year old boy 
with MPNST Right gluteal region (case No 25), since limb salvage and 
posterior flap hemipelvectomy  was not possible for him as the 
gluteal region was contaminated by inappropriate placed incision 
biopsy done elsewhere (Figure No 1a -1h). There was no post 
operative complication or flap necrosis and the patient was made 
ambulant. 
Composite pelvic exenteration (total sacrectomy) + end 
Colostomy was done in a 29 year old male, (case No12) with Giant 
cell tumor sacrum infiltrating the rectum. Post operatively the patient 
developed complete wound dehiscence, necrosis & 
Vesicocutaneous fistula. He died on the 60th post operative day 
because of pulmonary thromboembolism. 
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Sacrectomy was performed by either one of the following 
approaches: posterior approach (2 patients), Sequential abdomino-
sacral approach (8 patients), and staged abdomino-sacral 
approach (7 patients).  
In the Staged abdomino-sacral approach, on the day one of 
operation, with the patient in supine position, midline laparotomy 
was done, and the iliac vessels, rectum, anterior aspect of sacrum & 
tumor was defined. Vascular control of iliac vessels obtained (Fig No 
2a). Level of amputation planned and anterior osteotomy done. For 
adequate hemostasis, the pelvic cavity is packed with Gel foam & 
Roller Gauze pack (Fig No. 2b) (which is removed on the next day 
during the posterior approach). Abdomen is closed with pelvic drain. 
On the day two of operation, with the patient in prone position, 
posterior approach done – lumbosacral laminectomy done, dura 
identified & ligated, tumor delineated, uninvolved sacral nerve roots 
preserved, sacral amputation completed & specimen and the pack 
removed (Fig No.2c-e). The dura is ligated doubly with 2-0 silk. And 
gel foam is kept over it or muscle cover is done with paraspinal 
muscles. 
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In our series, this method of performing the operation on two 
subsequent days has markedly reduced the patient morbidity in 
terms of blood loss, reduction of operating time, anesthetic 
complications, wound healing thereby patient’s functional outcome 
and post operative hospital stay. 
In our series, we define the operation (Fig No.3) as 
• Total sacrectomy: when the level of amputation is at L5S1 disc 
with complete removal of sacrum. Even if, only the ala on one 
side of S1 vertebra is retained and rest of the sacrum is removed, 
we consider the operation as Total Sacrectomy. 
• Subtotal sacrectomy: when the level of amputation is at the body 
of S1 vertebra, through the level of S1 foramina, preserving the S1 
nerve root and both the ala of S1 vertebra are preserved, we 
consider the operation as subtotal sacrectomy (spinopelvic 
continuity is maintained) 
• Partial sacrectomy: when the level of amputation is at or below 
the body of S2 vertebra, through the level of S2 sacral foramina, 
preserving the S2 nerve root, we consider the operation as partial 
sacrectomy. 
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Whenever feasible, we try to preserve the uninvolved nerve 
roots irrespective of the bone cut made.   
Soft tissue reconstruction was done with Bilateral Gluteal 
advancement flap in 6 patients (table No 4). Omental flap has also 
been used to isolate the peritoneal cavity from the pelvic cavity. 
Table No 4 
            Soft Tissue Reconstruction 
 
Total n=6 
Sacrectomy n=4 Gluteal advancement flap 
Pelvic resection n=2 
 
Although Spinopelvic reconstruction was not done in any of the 
patients in the Sacrectomy group, none of our patients developed 
major spinal instability since the transverse process of L5 vertebra & 
the iliolumbar ligaments were left undisturbed even in total 
sacrectomy.  
Pelvic resection was done by utilitarian pelvic incision 
approach. 5 patients in hemipelvectomy group underwent bony 
reconstruction (Table No 5). 
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Table No 5 
BONY 
RECONSTRUCTION 
n Diagnosis  Procedure done 
Fibular strut graft 1 Aneurysmal 
Bone Cyst Right 
Ilium 
Type IV Pelvic Resection 
Right + Fibular strut graft 
DCP plate & screw 
fixation 
1 PNET Pelvis Type II + III Pelvic 
Resection Lt + DCP plate 
& screw fixation 
Cadaveric 
allograft bone 
transplantation 
1 Chondrosarcom
a pelvis 
Type II Pelvic Resection Rt 
+ Cadaveric allograft 
bone transplantation 
Extra Corporeal 
Pelvic Bone 
Irradiation & 
→reimplantation 
1 Ilium tumor-
Hemangioendot
helioma 
Type IV Pelvic Resection 
Rt → Extra Corporeal 
Pelvic Bone Irradiation  & 
→reimplantation 
Iliofemoral 
arthrodesis 
1 Ewing's sarcoma 
pelvis 
Type II + III Pelvic 
Resection Lt + Iliofemoral 
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arthrodesis 
 
Type IV pelvic resection & reimplantation of the Extra Corporeally 
irradiated Pelvic Bone was done for a 13 year old boy with right ilium 
tumor (Hemangioendothelioma) [Figure No 4 a-e]. Extracorporeal 
irradiation of the specimen was done by Cobalt Teletherapy with AP 
& PA portals to a total dose of 50Gy. Irradiated pelvic bone 
reimplanted into its position & fixed with plate & screws.  
But after 2 months, the patient developed osteomyelitis and 
autograft rejection and so the autograft was removed.  
There are very few reports of Intra-operative extracorporeal 
irradiation and re-implantation of the bone segment.  Extracorporeal 
irradiation is ideally done with Linear Accelerator.  
Advantages being: large doses of RT can be delivered to the 
tumor while avoiding the dose delivered to other tissues, the 
autograft fits aptly in its native anatomical position, easy availability,  
good adaptation of size & shape, no risk of disease transmission, 
preservation of bone stock and ligamentous tissue, and no 
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immunologic reaction. There is no evidence of increased rate of 
recurrence with extracorporeal irradiation & furthermore, no local 
recurrence been reported after extracorporeal irradiation.  
Complications include avascular necrosis & resorption of the 
graft fracture & non union. Another disadvantage is the lack of 
material for histopathological analysis of the resection margins. 
Type II + III Pelvic resection & Cadaveric allograft bone 
transplantation was done for a 28 year old male with recurrent 
chondrosarcoma of the periacetabular region. Reconstruction was 
done with freeze dried cadaveric pelvic bone. Allograft pelvic bone 
was tailored to suit the defect and fixed to the patient's pelvic bone 
with plates and screws at pubis and ilium (Figure 5 a -f). Femoral 
head was made to articulate with the graft's acetabulum and fixed 
with screws. Soft tissue reconstruction was done.  
 After 4 years, the allograft has completely resorbed and is 
replaced by fibrosis. The stability of the pelvis is good. Patient is 
ambulant independently without any assisting devices and is able to 
carry out his routine activities with an excellent functional outcome. 
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 Although the graft has completely resorbed, it has provided a 
lattice for fibrosis to occur. In spite of its limitations, allograft is an 
attractive option because of the low cost involved and the potential 
to acquire large number of grafts easily. 
The mean blood transfused in the whole series is 6 units; 8 units 
in the Sacrectomy group & 3 units in the Hemipelvectomy group. The 
average duration of surgery is listed in the Table No 6. 
Table No 6 
 Total 7 hours 
Sacrectomy 7 hours  
AVERAGE DURATION OF 
SURGERY 
Hemipelvectomy 6 hours 
 
The post operative complications were enumerated in the 
table No 7 & Chart No 2. Overall 15 patients (57.7%) developed post 
operative complications which is comparable to that in literature of 
50-70%.  
Most patients developed wound problems like wound 
dehiscence and necrosis. Wound complications were managed 
60 
 
either with debridement, SSG, secondary suturing, gluteal 
advancement flap or healing by secondary intention. 
Majority of the wound dehiscence in our series was observed to 
be due to extensive soft tissue resection, prolonged duration of 
surgery, primary closure of the wound without Gluteal advancement 
flap, necessity to ligate Superior Gluteal vessels, associated co 
morbid conditions of the patient and prior Radiation.  
Table No 7 
POST OPERATIVE 
COMPLICATIONS 
TOTAL SACRECTOMY HEMIPELVECTOMY 
Wound 
Dehiscence/ 
Necrosis 
n=15 n=10 n=5 
Bladder/ Bowel 
Incontinence 
n=9 n=9 n=0 
Meningitis n=1 n=1 n=0 
Posterior Defect 
Rectal Hernia 
n=1 n=1 n=0 
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DVT n=1 n=0 n=1 
Vesicocutaneous 
Fistula 
n=1 n=1 n=0 
Pulmonary 
Thromboembolism 
n=1 n=1 n=0 
  
Bilateral gluteal advancement flap was performed in 7 cases, 6 
at the same stage and one for the management of rectal herniation 
through the sacral defect.  
9 patients (34.6%) developed bladder & bowel disturbances. 
Bladder incontinence was managed either with intermittent self 
catheterization or with Diapers. Bowel problems were managed with 
regular enemas.  
Perioperative mortality in our series is 7.69% (n=2) which is in the 
range with that of literature of 5 – 10%. One patient (case No 17) in 
the sacrectomy group died on the 60th post operative day due to 
meningitis & septicemia.  
The other one, as already mentioned above, was a 29 year old 
male with Giant cell tumor of sacrum (case No 12) who underwent 
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composite pelvic exenteration + Total sacrectomy + end colostomy 
died on the 60th post operative day due to pulmonary 
thromboembolism.  
Posterior Defect Rectal Hernia in the case No 5 was managed 
with hernia repair & Bilateral Gluteal advancement flap.  
The average post operative hospital stay was 42 days in the 
whole group, 47 days in the Sacrectomy group & 32 days in the 
Hemipelvectomy group. 
The post operative morbidity in sacrectomy is significantly less in 
the staged abdomino-sacral approach when compared to the 
Sequential abdomino-sacral approach. (Table No 8) 
 
Table No.8 Comparison between the sequential & staged abdomino 
sacral approaches 
 
 
SACRECTOMY 
APPROACH 
n Mean 
operating 
time 
( Hours) 
Mean 
Blood 
transfused 
(in units) 
Wound 
complication 
rate 
Anesthetic 
recovery 
Average 
post op 
stay(in 
days) 
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Sequential 
abdomino-
sacral  
8 8 11 6 cases-75% Delayed 53 
Staged 
abdomino-
sacral 
approach 
7 6 3.7 4 cases –  
57 % 
Not 
affected 
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From the table No 8, it is obvious that with the staged 
abdominosacral approach of sacrectomy, the mean operating time 
is 2 hours less, wound complications are ≈20% less, and the average 
length of hospital stay is 11 days less when compared to the 
Sequential abdomino-sacral approach.  
Adjuvant Chemotherapy was given in 4 cases (PNET Pelvis, 
Ewing’s sarcoma Pelvis, PNET Sacrum, Hemangioendothelioma ilium).  
Adjuvant radiation was not given in any of the patients 
(excluding the case of extra corporeal pelvic bone irradiation). 
With a median follow up of 19 months (range 2-147 months), 
the survival rates are as follows: (Table No 9; Graph No 1, 2 & 3). 
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 5 year Overall survival  
9 Sacrectomy group is 65%  
9 Hemipelvectomy group is 76%.  
 5 year Disease free survival  
9 Sacrectomy group is 68%  
9 Hemipelvectomy group is 76%  
 5 year Overall survival  
9 non recurrence group is 78%  
9 recurrence group is 50%   
 Although the p value (by log rank analysis) is not significant (p 
value - 0.4678), there is a substantial difference between the 
recurrence and non recurrence group. 
 
 
Table No 9 
SURVIVAL 
ANALYSIS 
SACRECTOMY HEMIPELVECTOMY LITERATURE 
5 year Overall 65% 76% 50-60% 
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survival 
5 year Disease free 
survival 
68% 76% 50% 
 
Local recurrence (n=5) rate was 19.32%. In two cases, the 
recurrence was resected and the patients are disease free on follow 
up. 
 
 The median duration for 1st recurrence was 12 months (range 3-
17) 
 4 patients developed distant metastasis  
 pulmonary metastasis - 3 patients  
 Liver & vertebral metastasis - 1 patient 
The current status of the patients is enumerated in the table No 
10 & Chart No 3.  
 
 
 
Table No 10 
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Current status Total Sacrectomy Hemipelvectomy 
Lost Follow Up 10 4 6 
Local 
Recurrence 
5 4 ( 2 operated 
& disease free 
now) 
1 
Distant 
Metastasis 
4 2 2 
Death 7 5 (including 2 
perioperative 
mortality) 
2 
 
The functional outcome was assessed according the 
Royapettah scoring scale for musculoskeletal tumors of pelvis; (Chart 
No 4). 
9 good outcome - 12 patients (46%) 
9 fair outcome    -  8 patients (31%) 
9 poor outcome  - 6 patients (23%) 
77% of our patients had an acceptable functional outcome 
(good or fair). And only 23% did not fare well after surgery. Overall 
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the results & outcome (oncological and functional) in our series is in 
par with that reported in the literature. 
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Figure 1:Photographs of case No 25 (MPNST right gluteal region) – Anterior Flap 
Hemipelvectomy was done 
Figure 1a):Wrongly placed Biopsy incision 
 contaminating the posterior flap         
     Fig 1b):External iliac vessles isolated 
    
 
 
 
  
Fig 1c) Anterior thigh myocutaneous flap isolated Fig 1d; Hemipelvectomy completed: defect 
showing the cut ends of sacrum posteriorly, 
cut end of pubis anteriorly, Bladder & 
Rectum inbetween: anterior thigh flap 
reflected above 
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Fig 1e) Defect closed with the anterior flap                                fig 1f) resected specimen 
photograph 
 
 
 
 
 
   
Fig 1 g& h) the wound healed well; patient is made to walk with crutches  
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Figure 2: photos of case  17 (chondrsarcoma of sacrum)–subtotal sacrectomy+Type I pelvic resection 
 
 
Figure 2a): Abdominal procedure of the 2 staged sacrectomy: anterior approach & vascular 
isolation of iliac vessels. [Rectum (lower arrow mark) mobilized aside: iliac vessels delineated 
(upper arrow mark)] 
 
 
Figure 2b) anterior approach is completed & gelfoam (A) & roller gauze pack (arrow mark) 
packed into the cavity for hemostasis 
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Figure 2c) 2nd stage (sacral approach) of 
the staged abdominosacral approach: 
sacrectomy is on the way; the arrow mark 
showing the dissected specimen 
 
 
Figure 2d); posterior approach; 
Lumbosacral  
Laminectomy done and the dura exposed 
 (As shown by the black arrow mark) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2e) specimen photograph 
 
Fig 3-  Picture representing the levels of 
amputation. A-Total sacrectomy; B-Subtotal sacrectomy; 
C-Partial sacrectomy; D-Hemisacrectomy  
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Figure4: case No 18: Hemangioendothelioma Right ilium; Pelvic resection & reimplantation of 
erxtracorporeally irradiated pelvic bone  
            
Fig 4a) utilitarian pelvic incision including the  Fig 4b) after completion of resection 
biopsy scar 
        
Fig 4c) After resection, soft tissues of the   Fig 4d) autograft packed in a sterile 
specimen removed      container for extra corporeal irradiation 
  
 
Fig 4e) Post operative X-ray showing the autograft in situ. 
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Figure 5: Photographs of case No 21 (Recurrent Chondrosarcoma of actebulum) 
– Type II + III pelvic resection followed by allograft reconstruction 
           
Fig 5a) Defect after resection   Fig 5b) Specimen photograph  
Femoral head in disarticulated position.  
 
       
Fig 5c &d): Freeze dried Allograft which was osteotomized to suit the defect. 
          
Fig 5e): Allograft is placed in defect,         Fig 5f) Immediate post operative X ray showing 
to be fixed with screws and plates    allograft fixed with plates and screws 
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Chart No 1 
 
 
 
 
Chart No 2 – Post operative complications 
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Chart No 3 
 
 
 
 
 
 
 
 
Chart No 4 
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Graph No 1:   5 year Overall survival 
 
 
 
Sacrectomy – 5yr overall survival 65%; Hemipelvectomy – 5 yr overall survival – 76%  
 
Graph No 2:    5 year Disease free survival 
 
 
 
Sacrectomy –5 year DFS - 68%; Hemipelvectomy – 5 year DFS 76% 
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Graph No 3: 5 year Overall survival in recurrence and non 
recurrence group 
 
 
 
 
 
No recurrence – overall survival -78% 
Recurrent group – overall survival 50% 
 
Test Statistic D.F. P-Value 
Log-Rank 0.5273 1 0.4678 
Wilcoxon 0.0072 1 0.9326 
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CONCLUSION 
Bone and soft-tissue sarcomas that arise in the pelvis are 
difficult to treat. Tumors can be large and destructive before 
discovery, and they often involve vessels and nerves. Achieving a 
wide or even a marginal surgical resection margin may be 
technically complex at times.  
Historically, patients with pelvic tumors were treated with 
hemipelvectomies. These operations not only were fraught with 
complications but also in most cases represented physical, 
functional, and psychological problems for the patients.  
Several studies have described the difficulties patients have 
with such a procedure, and there is little doubt that regardless of the 
problems associated with the internal hemipelvectomies and 
reconstructions, such procedures are preferred to total limb ablation. 
Sacrectomy, one of the neglected & morbid operations, is 
feasible now with modified and improved surgical techniques. 
Although a morbid procedure, sacrectomy with improved surgical 
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techniques improves oncological outcome and patients’ quality of 
life.  
The staged abdomino – sacral approach significantly reduces 
the mean operating time, blood loss, wound complications and 
immediate post operative morbidity. Gluteal advancement flap 
reduces the incidence of wound dehiscence and necrosis. 
Sacrectomy is feasible with moderate surgical facilities and post 
operative care by the staged abdomino sacral approach. 
It seems that the critical comment regarding all this is that 
almost no matter what the tumor is and how it is treated, 50% of the 
patients survive, particularly if the margins are marginal or wide and 
adjunctive treatment is administered. That level of success is not as 
good as we would like, but it is certainly a baseline start to see if 
some efforts will help improve the outcome.  
Based on the data, the approaches must include improved 
surgical techniques, altered adjuvant therapy protocols, and better 
mechanical restoration systems. These are clearly the directions we 
must take if we are to improve the status and outlook for these 
patients. 
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SURGICAL OUTCOME OF MUSCULOSKELETAL 
TUMORS OF PELVIS 
PROFORMA 
 
S.No 
Name :                                                                  C.D No    
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Age:                                                                     C.OP No  
Sex:        I.P. No 
Occupation:       Address 
D.O.A:                                                        (& Ph No) 
D.O.S : 
D.O.D: 
 
DIAGNOSIS  
TNM STAGING  
STAGE GROUPING  
 
COMPLAINTS AND DURATION: 
Swelling           Y/N 
Pain          Y/N 
Weakness of Limbs/Difficulty in walking  Y/N 
Pain of Lower Limbs (radiating)   Y/N 
 
Sensory Disturbance     Y/N 
(Loss of Sensation/Altered Sensation) 
Swelling of Limbs/Foot     Y/N 
 
Urinary Symptoms     Y/N 
(Incontinence/Retention/Frequency/ 
Hematuria/Dysuria) 
 
Altered Bowel Habits     Y/N 
(Incontinence/Constipation/ 
Diarrhoea/Bleeding PR) 
Loss of Appetite      Y/N 
Loss of Weight      Y/N 
Family H/o Malignancy     Y/N (1st /2nd/3rd Degree                  
        Relative) 
Previous H/o Malignancy    Y/N 
 
H/O PREVIOUS TREATMENT   
Surgery 
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Radiotherapy: Total Dose:  No. of Fractions: Completed On 
Chemotherapy:Drugs   No.of Cycles 
 
Previous Biopsy      Y/N 
Type     (FNAC/Core Needle Biopsy/Incision Biopsy/Excision Biopsy) 
Histology 
 
Smoker/Alcoholic/Nonsmoker/Nonalcoholic:   Married/Unmarried 
Comorbid Illness     DM/HTN/IHD/COPD/TB 
 
CLINICAL EXAMINATION: 
Performance Status (ECOG scale)   0 / I / II / III / IV 
Previous Biopsy Scar     Y/N 
Site:    Length: 
Orientation of the scar with respect to future definitive surgical planning & incision 
 
EXAMINATION OF SWELLING 
Site & Size 
Mobile/Fixed 
Skin involvement      Y/N 
Bone involvement      Y/N 
Bone involved 
Soft tissue involvement     Y/N 
Muscle involvement     Y/N 
Muscles involved 
Vascular involvement     Y/N 
Vessel affected 
Nerve involvement     Y/N 
Nerve affected 
Lower limb edema      Y/N 
Unilateral/Bilateral 
Pitting/Non pitting 
ARTERIAL PULSE OF LOWER LIMB 
ARTERIAL PULSE RIGHT LEFT 
Femoral    
Popliteal    
Dorsalis pedis   
Posterior Tibial   
 
POWER OF LOWER LIMB  
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(MRC classification) 
MOVEMENT RIGHT LEFT 
HIP   
Flexion / 5 / 5 
Extension / 5 / 5 
Abduction / 5 / 5 
Adduction / 5 / 5 
External rotation / 5 / 5 
Internal rotation / 5 / 5 
KNEE   
Flexion / 5 / 5 
Extension / 5 / 5 
ANKLE   
Dorsiflexion / 5 / 5 
Plantar flexion / 5 / 5 
TOES   
Dorsiflexion / 5 / 5 
Plantar flexion / 5 / 5 
 
SENSATION      Rt    Lt 
Anesthesia/Paraesthesia 
Area affected 
Dermatomes affected 
 
DIGITAL RECTAL EXAMINATION 
Mass felt Y/N: Anteriorly / Posteriorly / Rt Lateral / Lt lateral 
Mucosa involved: Y/N:  Sphincter tone 
 
LYMPH  NODES      Y/N 
Site 
 
DISTANT METASTASIS    Y/N 
Site 
 
INVESTIGATIONS 
Hb%      Blood sugar:   
Blood urea:    S.Creatinine: S.Alkaline Phosphatase 
 
FNAC 
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BIOPSY: Core Needle Biopsy/ Incision Biopsy/ Excision Biopsy     
Histology  Grade  Immunohistochemistry 
 
CHEST X-RAY          
Normal 
Lung Metastasis: Single / multiple (2 / 3 / 4 / 5 / >5): Unilateral / Bilateral 
 
LOCAL PART X-RAY 
Site & Size of lesion 
Type      Osteolytic/Osteosclerotic/Mixed 
Calcification       Y/N 
Margin       well defined/ill defined 
Cortical destruction     Y/N 
Pattern of destruction    Geographical / permeasive/Moth eaten 
Extraosseous extension     Y/N 
Periosteal elevation     Y/N  
 
CT SCAN LOCAL PART/ MRI SCAN 
Site & Size        
Infiltrating adjacent structures    Y/N 
Structure infiltrated 
Extension into sciatic notch    Y/N 
Margin       well defined/ill defined 
Bone involved       Y/N 
Bone destruction       Y/N 
Muscles involved 
Nerve       displaced/involved/not involved 
Nerve affected 
Blood Vessel        displaced/involved/not involved  
Blood vessel affected 
Calcification       Y/N 
Hemorrhage       Y/N 
Necrosis       Y/N 
Bladder involved       Y/N 
Rectum involved       Y/N 
 
BONE SCAN 
CT SCAN CHEST  
Normal 
Lung Metastasis: Single / multiple (2 / 3 / 4 / 5 / >5): Unilateral / Bilateral 
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TREATMENT 
NEOADJUVANT CHEMOTHERAPY  Y/N 
Drugs  No. of cycles  Response  
 
SURGERY 
SACRECTOMY  Total / Subtotal/ Partial/ Hemisacrectomy 
   
Approach 
Level of resection 
Nerve roots sacrificed 
Nerve resected 
Dura intact    Y/N 
CSF leak (intra operative)    Y/N 
 
HEMIPELVECTOMY (CLASSICAL) 
Posterior Flap Hemipelvectomy/Anterior Flap Hemipelvectomy  
Standard/ Extended/ Modified (Conservative)/ Compound   
Adjacent organ removed ……………..    
 
PELVIC RESECTION      TYPE I/II/III/IV 
Vascular Resection 
Vascular Reconstruction 
Nerve resection 
Reconstruction       Y/N 
 
Reconstruction with     saddle prosthesis  
       allograft 
       prosthesis replacement 
       iliofemoral arthrodesis 
       ischiofemoral arthrodesis 
 
Colostomy       Y/N 
Ileostomy       Y/N 
Ileal conduit       Y/N 
Colonic conduit       Y/N 
Duration of Surgery  
Blood Loss 
Blood transfusion given  
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POST OPERATIVE COMPLICATION 
Wound infection       Y/N  
Wound dehiscence      Y/N 
Flap necrosis       Y/N 
Treated by        secondary suturing 
       Wound debridement 
       SSG 
       Flap reconstruction 
       Healing by secondary intention 
Fistula 
Thromboembolic manifestation    Y/N 
Colostomy/ Ileostomy complication   hernia/ stenosis 
Urinary leak       Y/N 
Duration of post operative stay (in days)   ………. 
 
Bladder function 
Incontinence      Y/N 
(Urge incontinence/stress incontinence) 
Filling sensation       Y/N 
Voiding  
 
Defecation disturbance      Y/N 
Incontinence/Constipation     
 
Impotence       Y/N 
Phantom limb sensation /pain    Y/N 
Reduced by analgesics     Y/N 
 
MORTALITY 
Died on ……………post operative day 
Cause of death 
 
POST OPERATIVE H.P.E 
Histology    Grade     IMMUNOHISTOCHEMISTRY 
 
ADJUVANT CHEMOTHERAPY   Y/N   
Started on:             Drugs:   No. of cycles 
 
ADJUVANT RADIOTHERAPY   Y/N   
Started on  
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EBRT/Brachytherapy/both  Total dose  No of fractions 
 
FOLLOW UP   
      Date of visit: 
      Follow up No.: 
POWER OF LOWER LIMB (MRC classification) 
MOVEMENT RIGHT LEFT 
HIP   
Flexion / 5 / 5 
Extension / 5 / 5 
Abduction / 5 / 5 
Adduction / 5 / 5 
External rotation / 5 / 5 
Internal rotation / 5 / 5 
KNEE   
Flexion / 5 / 5 
Extension / 5 / 5 
ANKLE   
Dorsiflexion / 5 / 5 
Plantar flexion / 5 / 5 
TOES   
Dorsiflexion / 5 / 5 
Plantar flexion / 5 / 5 
 
NEUROLOGIC DEFICIT      
Paraplegia       Y/N 
Paraperesis       Y/N 
Foot drop       Y/N 
Sensory loss       Y/N 
 
BLADDER FUNCTION 
Incontinent/continent 
Feel the sense of filling/voiding    Y/N 
 
BOWEL HABITS 
Incontinence/Constipation 
 
PAIN       Y/N 
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Bearable or Unbearable  
Does it interfere with daily activities    Y/N 
 
PHANTOM LIMB PAIN/SENSATION  Y/N 
 
WALKING 
Able to walk        Y/N 
Walking without support     Y/N 
Walking with support     Y/N 
(Walker/crutches/calipers) 
 
GAIT 
 
CLIMB THE STAIRS UP/DOWN   Y/N 
With support        Y/N 
Without support       Y/N 
 
PERFORM DAILY ROUTINE ACTIVITIES Y/N 
(Dressing/bathing etc) 
Independently       Y/N 
Dependent (partly/fully)     Y/N 
 
HAS THE Pt RETURNED TO HIS/HER ORIGINAL OCCUPATION?  Y/N 
If not, why? 
 
EMOTIONAL ASPECT 
Worried       Y/N 
Depressed       Y/N 
SOCIAL/FAMILY WELL-BEING 
Interacts with friends & family members  Y/N 
Family /friends support the patient   Y/N 
ONCOLOGICAL OUTCOME 
 
     
PARAMETERS 1 2 3 4 5 6 7 8 9 10 11 12 
Date 
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Disease free Y/N 
 
            
Recurrence Y/N 
 
            
Date of 
rence 
            
Site of 
recurrence 
            
Local 
 
            
Regional 
 
            
Distant 
metastasis Y/N 
 
            
Site of metastasis 
 
            
 
 
 
 
 
 
   
FUNCTIONAL OUTCOME ASSESMENT SCORE 
 
S.No Factor Normal (4) Near 
Normal(3) 
Acceptable 
(2) 
Poor 
(1) 
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1 Pain No pain / mild 
pain 
-Moderate 
pain 
-Tolerable 
-Does not 
need 
analgesics 
-Severe 
pain 
-Reduced 
by 
analgesics 
-Very severe 
intolerable 
pain 
-Not 
reduced by 
analgesics 
-Disturbs 
sleep/routine 
activities 
2 Locomotion Walk without 
support 
Walk with 
support/single 
crutch 
Walk with 
double 
crutches / 
walker 
Not able to 
walk  
3 Sensory 
Deficit 
Normal Sensory 
deficit 
detected on 
clinical 
examination 
-Sensory 
deficit felt 
by the pt. 
-Pt feels the 
discomfort 
Trophic ulcer 
& other 
secondary 
changes 
4 Bladder & 
Bowel 
Function 
Both normal Mild 
dysfunction 
 
Severe 
dysfunction  
Acceptable 
Very severe 
dysfunction 
5 Pt ‘s 
Acceptance 
Very good Good Fair Poor 
6 Ability to 
return to 
work  
(including 
work at 
home ) 
Does it 
independently 
-Able to do 
with minimal 
assistance  
-modified 
pattern of 
work 
Able to do 
only with 
assistance 
Does’nt do 
work 
 
TOTAL SCORE -     / 24  
RESULT 
GOOD    SCORE 19 – 24   
FAIR   SCORE 13 - 18   
POOR  SCORE 6 - 12  
 
 
FUNCTIONAL OUTCOME ASSESMENT SCORE 
94 
 
 
S.No FACTOR NORMAL 
(4) 
NEAR 
NORMAL 
(3) 
ACCEPTABLE 
(2) 
POOR 
(1) 
1 Pain 
 
    
2 Locomotion 
 
    
3 Sensory 
Deficit 
    
4 Bladder &  
Bowel 
Function 
 
    
5 Pt ‘s 
Acceptance 
    
6 Ability to 
return to 
work  
(including 
work at 
home ) 
    
 
 
 
TOTAL SCORE -    / 24   
 
RESULT   
GOOD    SCORE 19 – 24   
 
FAIR     SCORE 13 - 18   
 
POOR    SCORE 6 - 12 
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1
PARAMA
SIVAM 20/M 4049
Sacral 
tumor- 
GCT + + + + + - - Total Sacrectomy 13/02/97
Sequentia
l  A & P
*Body of  
S1, B/L 
sacral 
alae
2 C.V.LIJU 19/M 5769/99
Sacral 
tumor-
Chordoma + + - - - - - Partial sacrectomy 2/9/1999 Posterior *S2
3
NIDHIN 
GEORGE 15/F 4961
Sacral 
tumor- 
GCT + + - + + - -
Partial sacrectomy & 
Curettage 18/03/00
Sequentia
l  A & P
*Junction 
between 
S2,S3
4
NARAYA
NI 52/F 306/01
Sacral 
tumor-
Chordoma - + - - - - - Partial Sacrectomy 23/02/01
Sequentia
l  A & P *S3
5 ASHOK 35/M 340/02
Sacral 
tumor- 
GCT + + - - - + + Total Sacrectomy 6/8/2002
Sequentia
l  A & P *S1
6
MUTHUL
AXMI 39/F
Sacral 
tumor- 
GCT - + + - - - - Partial Sacrectomy 9/8/2003
Sequentia
l A&P
*Junction 
between 
S2,S3
7 SURESH 15/M 6503
Sacral 
tumor- 
GCT - + - - - - -
Partial sacrectomy & 
Curettage 13/08/03
Sequentia
l  A & P
*Junction 
between 
S2,S3
8 UMA 33/F 7177
Sacral 
tumor- 
GCT - + - - - - - Partial Sacrectomy 30/08/04
Sequentia
l  A & P
*S2,3,4 
Extending 
to Rt SI 
joint
9
UMAKAN
TAN 22/M 7789
Sacral 
tumor -
Myxopapil
lary 
ependymo
ma - + - - - - - Partial Sacrectomy 20/06/05
Sequentia
l  A & P *S2
10 ABIRAMI 30/F Sep-08
Sacral 
tumor-
Chondrobl
astoma Partial Sacrectomy Posterior *S3
11
BEE BEE 
JOHN 61/F 383/06
Sacral 
tumor-
Chordoma + + + + + + + Total Sacrectomy 10/6/2006
Staged 
A&P *S1
12
THIRUPA
THIAH 29/M 831/06
Sacral 
tumor- 
GCT + + + + + + +
Composite Pelvic 
exenteration(Total 
Sacrectomy)+Colosto
my 4/8/2006
Staged 
A&P *S1
13 MARY 20/F 741/06
Sacral 
tumor- 
PNET - + + + - - -
Partial Sacrectomy ( 
Left Hemisacrectomy 
) 19/07/06
Staged 
A&P
Left 
Hemisacr
um
14
DHANAS
EKAR 48/M 578/07
Sacral 
tumor-
Chordoma + + + + + + + Subtotal Sacrectomy 29/05/07
Staged 
A&P *S2
15 SUNDARI 50/F -
Sacral 
tumor-
Chordoma + + + + + + + Subtotal Sacrectomy 2007
Staged 
A&P *S1
16
KAIRUNI
SHA 65/F 870/08
Sacral 
tumor-
Chordoma + + + + - + + Subtotal Sacrectomy 26/08/08
Staged 
A&P *S1
17
RANGAN
ATHAN 54/M 1682/08
Sacral 
tumor - 
chondrosa
rcoma + + + + + - -
Subtotal Sacrectomy 
+ Type I Pelvic 
Resection (Lt) 12/11/2008
Staged 
A&P
*Left half 
of S1 
body , SI 
joint , Left  
Ilium
18
PARTHE
EBAN 13/M 682/05
Ilium 
tumor-
Hemangio
endothelio
ma + + - - - - -
Type IV Pelvic 
Resection Rt → Extra 
Corporeal Pelvic 
Bone Irradiation 
5oGy- 25Gy/#-2# & 
→reimplantation 16/09/05
Abdomino 
Lateral-
Localio
Right 
Ilium 
tumor 
infiltrating 
sacral ala
19
PERIYAS
AMY 22/M 1215/03
Aneurysm
al Bone 
Cyst Rt 
Ilium + + + + + - -
Type IV Pelvic 
Resection Rt + 
Fibular strut graft 5/1/2004
Abdomino 
Lateral-
Localio
Right 
Ilium 
tumor 
infiltrating 
sacral ala
20 RANJITH 18/M 1029/03
PNET 
Pelvis + + + + + - -
NAC (PVCE)  
4cycles→Type II + III 
Pelvic Resection Lt 7/1/2004
Utilitarian 
pelvic 
incision
Lt pubic 
ramus & 
obturator 
fossa
21
PRAKAS
H 33/M 266/01
Chondros
arcoma 
pelvis + + + + - - -
Type II +III Pelvic 
Resection Rt 
+Cadaveric allograft 
bone transplantation 26/8/04
Utilitarian 
pelvic 
incision
periacetab
ulam
22
SHRIL 
WILLIAM
S 38/M 1111/04
Chondros
arcoma Rt 
Ilium + + - - - - -
Type IV Pelvic 
Resection Rt 23/11/04
Utilitarian 
pelvic 
incision
Rt Ilium, 
Rt SI 
Joint, Rt  
S2-3 
sacral 
foramina 
23 SHEELA 34/M 833/05
Chondros
arcoma Rt 
Ilium + + - - - - -
Type IV Pelvic 
Resection Rt 4/5/2005
Utilitarian 
pelvic 
incision
Rt Ilium, 
Rt SI 
Joint, Glut 
medius/ 
minimus, 
iliacus 
24
THENMO
ZHI 16/F 438/05
Ewing's 
sarcoma 
pelvis + + + + - - -
NAC-VAC (3) →Type 
II + III Pelvic 
Resection Lt 11/5/2005
Utilitarian 
pelvic 
incision
Acetabulu
m & Pubis
25
ESWARI
AH 16/M 567/06
MPNST 
Rt Gluteal 
region + + + + - - -
Anterior Flap  
Hemipelvectomy 
(External) 17/6/06
Utilitarian 
pelvic 
incision -
26
RANGAS
AMY 60/M 1008/07
Chondros
arcoma Rt 
Ilium + + - - - - -
Type I+II Pelvic 
Resection 16.8.07
Utilitarian 
pelvic 
incision
Rt Ilium & 
periacetab
ulum
Ex
te
nt
 o
f R
es
ec
tio
n/
 *A
M
PU
TA
TI
O
N
 L
EV
EL
*lower border of L5 
vertebra
*Lower border of 
body of S2 vertebra 
&  below S2 sacral 
foramina
*Upper border of S2
*Lower border of 
body of S2 vertebra 
&  below S2 sacral 
foramina
*lower border L5 
vertebra
*Lower border of 
body of S2 vertebra 
&  below S2 sacral 
foramina
*Lower border of 
body of S2 vertebra 
&  below S2 sacral 
foramina
*Body of S2 vertebra
*Upper border of S2 
vertebra;
On the right side → 
above S2 foramina
On the left side →  
below the S2 
foramina
*S2 Lower border
*L5S1 disc
*L5S1 disc
*L5S1 disc & middle 
of sacrum ( left 
Hemisacrum)
*Lower border of 
body of S1 vertebra 
&  below S1 sacral 
foramina
*Upper border of 
body of S1
*Upper border of 
Body of S1; right side 
→ above S1 
formaina; left side → 
below S1 foramina
*thru L5S1 disc 
anteriorly &Lt 
laterally, including  Lt 
SI joint, Lt Ilium; 
preserving only Rt 
half of S1,S2 body
Rt Ilium + part of 
sacral alae 
Rt Ilium + part of 
sacral alae + ischium
Lt superior & inferior 
pubic ramus & ramus 
of ischium + femoral 
head
Pubis+ 
periacetabulam
Rt ilium, Rt SI Joint, 
sacral ala, Sciatic 
nerve
Ilium, 
periacetabulum, ala 
of sacrum, Head & 
neck of femur, 
Iliacus, glut medius & 
minimus, obturator N
acetabulum, pubis, 
femoral head
-
Type I+II Pelvic 
Resection
